Table 5.
Variables in the model of total subjects | ASAA outcome | sIL-2Rα outcome | sTNF-R1 outcome | |||
---|---|---|---|---|---|---|
(N = 142) | (N = 159) | (N = 159) | ||||
Beta∗ | p values | Beta∗ | p values | Beta∗ | p values | |
17-OH P5 | −0.216 | 0.023 | −0.116 | 0.268 | 0.334 | <0.001 |
DHEA | 0.286 | 0.013 | 0.200 | 0.044 | −0.013 | 0.872 |
Adione | 0.022 | 0.853 | −0.032 | 0.732 | −0.387 | <0.001 |
DHEAS | −0.147 | 0.129 | −0.147 | 0.130 | 0.177 | 0.021 |
LH | 0.084 | 0.365 | 0.030 | 0.772 | −0.094 | 0.255 |
Entry age | 0.226 | 0.016 | −0.102 | 0.292 | 0.006 | 0.936 |
| ||||||
Variables in the model of control subjects | ASAA outcome | sIL-2Rα outcome | sTNF-R1 outcome | |||
(n = 113) | (n = 126) | (n = 126) | ||||
Beta∗ | p values | Beta∗ | p values | Beta∗ | p values | |
| ||||||
17-OH P5 | −0.257 | 0.017 | 0.021 | 0.862 | 0.303 | 0.001 |
DHEA | 0.198 | 0.146 | 0.204 | 0.073 | 0.046 | 0.604 |
Adione | 0.170 | 0.209 | −0.092 | 0.390 | −0.450 | <0.001 |
DHEAS | −0.185 | 0.092 | −0.193 | 0.096 | 0.241 | 0.007 |
LH | 0.054 | 0.613 | 0.088 | 0.470 | −0.037 | 0.703 |
Entry age | 0.199 | 0.054 | −0.054 | 0.631 | 0.038 | 0.668 |
| ||||||
Variables in the model of pre-RA subjects | ASAA outcome | sIL-2Rα outcome | sTNF-R1 outcome | |||
(n = 29) | (n = 33) | (n = 33) | ||||
Beta | p values | Beta∗ | p values | Beta∗ | p values | |
| ||||||
17-OH P5 | 0.127 | 0.533 | −0.595 | 0.015 | 0.479 | 0.030 |
DHEA | 0.496 | 0.015 | 0.367 | 0.094 | −0.193 | 0.313 |
Adione | −0.618 | 0.015 | 0.123 | 0.552 | −0.198 | 0.272 |
DHEAS | −0.166 | 0.417 | 0.031 | 0.873 | 0.022 | 0.896 |
LH | 0.155 | 0.364 | −0.237 | 0.254 | −0.231 | 0.208 |
Entry age | 0.210 | 0.307 | −0.130 | 0.537 | −0.077 | 0.671 |
∗Standardized beta coefficients from linear regression of log-transformed, reported NEI biomarkers.